Global Drug Delivery Challenges Explained

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Global Drug Delivery Challenges Explained

Topic: Bio Break
YouTube video thumbnail

In this episode of Bio Break, Nick Allan and Nigel Syrotuck dive into the surprising realities of global drug delivery. While medical devices often dominate development conversations, the way drugs are delivered across regions can dramatically change how treatments succeed — or fail.

Nigel reflects on a trip to Italy where food sparked thoughts about oral drug delivery. In regions like Italy, pills and tablets are the most common approach. Larger countries also tend to prefer simple, scalable methods such as pills or injections. By contrast, smaller regions may be more open to specialized treatments that require more time or unique handling.

Regional Differences in Drug Delivery

Drug delivery methods are influenced not just by culture, but also by economics, insurance systems, and infrastructure. For example, biosimilars are more readily accepted in some countries depending on reimbursement structures. Meanwhile, large-scale programs — such as vaccine rollouts — highlight how fragile supply chains can be.

Cold Chain and Pandemic Lessons

Certain drugs, including attenuated vaccines, require strict cold chain maintenance. In developing regions, this presents a major challenge. The COVID-19 pandemic underscored this issue when millions of doses expired due to distribution and storage limitations. As Nick and Nigel note, a drug designed for one part of the world may face barriers to adoption in another, depending on the delivery method.

Enjoying Bio Break? Sign up to get new episodes sent to your inbox.

Subscribe to Bio Break
Magnifying glass revealing cracks with the text “This gets missed,” illustrating hidden risks in medical device validation and real-world use.

Medical Device Reprocessing Design Challenges

Ariana Wilson sits down with Mark Drlik to unpack why reprocessing is often one of the hardest challenges engineers face during development.

Thumbnail showing the text “ETO or Radiation?” with a cloud icon representing ethylene oxide sterilization and a radiating burst icon representing radiation sterilization for medical devices.

Medical Device Sterilization: Choosing Between ETO, E-Beam, and Gamma

Nick and Nigel walk through how teams decide between ethylene oxide, E-beam, and gamma radiation sterilization.

Medical device pilot manufacturing workspace showing engineers supporting NPI and scalable production

MedTech NPI: Where Product Value Is Won or Lost

In MedTech, success rarely comes from invention alone. Plenty of promising technologies make it through verification and early clinical work, only to stall when the team tries to turn them into something buildable.

Thumbnail showing bacterial growth from one cell to 10²¹ cells, illustrating rapid bacteria reproduction with text reading “This fast?” and a red arrow indicating exponential increase.

Bacteria Fun Facts

From how much of your body is actually bacterial to how fast microbes can multiply, these facts are designed to stick with you long after the party ends.